chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: ADMISSION DATE: 12/08/2021 DISCHARGE DATE: 12/14/2021 DISCHARGE TYPE: Regular PRINCIPAL DIAGNOSIS (Reason for admission after study):1) Acute-on-chronic hypoxic respiratory failure with COVID-19 viral pneumonia. 2) Acute SARS-CoV-2 pneumonia: Tested positive for COVID-19 on 12/08/21. signficant medical problems including CAD, chronic PVD, lung cancer s/p resected brain metastases, chronic hoarseness, tubular adenomas, history of seizures, Type II DM, HTN, HLD, COPD, left shoulder pain, IDA, OA, and GERD who presents to the ER c/o sob/productive cough/DOE for a week. He reports assoc nasal congestion and coughing up BRB. No reported fever. He had COVID-19 vaccines in March/April 2021. Patient reports ongoing dyspnea even prior to recent coronary stent placement but reports increased dyspnea on exertion and shortness of breath at rest for the last week associated with cough and cold symptoms. Of note, the patient reports undergoing 6-7 stents and the last stent placement was 3 weeks ago at Hospital. He is pain free now, but reports angina symptoms. In ER Triage reports, Patient reports increasing SOB, chills at night, cough, headache, congestion. COVID Tent assessment showed he was hypoxic at 86-89% on room air. ER work-up showed O2 sat was 93% on 3L/NC, CXR presented with SOB, Coughing, and hypoxia. He tested (+)for COVID- 19 with Viral Pneumonia. He received 5 day course of Remdesivir and ongoing tapering dose of IV, now PO Dexamethasone. He has qualified for home O2 2L/NC with activity and with activity. He is stable and anxious to get out of the hospital. His blood sugars were elevated due to the steroids. He will f/up with his PCP after 10 days of DH isolation guidelines.
12 hours after vaccination, woke up from sleep with low grade fever, body chills/shakes and nausea.  These symptoms lasted another 12 hours and then ceased.  I have previously recovered from covid earlier in November.
6 days following vaccine patient had blurred vision and collapsed; refused transport to hospital from EMS; 10 days after vaccine, patient suffered what was deemed to be a TIA but actually found to be an ischemic stroke.  Was speaking and was to be released to at home rehab; 1.5 days later suffered what appeared to be a stroke but brain MRI showed no change.  She now has C3 nerve involvement not related to the stroke and, speech and movement issues.   Cause undetermined.
Severe local reaction DTaP. Developed increased swelling, redness, now bruising (approximate size of tomato).
left upper extremity with diffuse erythema and swelling (approximately 6x6 cm), no induration, non-tender, no vesicles/pustules/mass
In the middle of the night, I felt like had been hit with a cold, my nose was running, I had a fever. I used a home COVID-19 test that came back positive, I called my doctor to let him know that I was positive and to discuss my symptoms. I was advised to go into an urgent care to have a PCR rapid test. I waited to talk to my doctor on Monday, I was prescribed PAXLOVID, I am noticing that my fever is going away but my cough is lingering, my sore throat is going away.
Started getting a prickly burning feeling on arm shot was admistered in across back to other shoulder, up the back of neck, head, ears, and face. Red blotchy rash developed. Did not seek treatment. symptoms disappeared in 1-2 hours. No change in diet was made prior. Ate a begal with cream cheese and drank water, nothing else ingested that morning... not sure if this was a reation to the H1N1 Vaccine or not, but felt I should report it.
Screaming, inconsolable crying, unable to make eye contact, blank stare, terrible rash on thigh that lasted 6+ weeks
After receiving the influenza vaccine, the patient experienced a local reaction with associated itching. After returning to the patient's room, the patient began experiencing SOB and appeared very anxious.
Red, warm to the touch, swollen, lump in arm. Area of reaction is larger than injection site.
This spontaneous report as received from a other health professional refers to multiple unspecifed patients of an unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored RECOMBIVAX HB lot # M035487, expiration date 23-FEB-2019 (strengtht, dose, frequency and route were not provided) for prophylaxis.  Data logger was involved. The temperature excursion was 34.1 F for a time frame of 45 minutes. No adverse effects reported. No product quality complaint was involved.
This spontaneous report as received from a registered nurse refers to a 6 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 05-DEC-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M031802 with expiry date: 09-NOV-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705.
Patient reported her tongue felt like it was getting larger- no visible enlargement on exam.  Patient was given 50mg of Diphenheramine by mouth with partial symptom resolution in 40 minutes and complete resolution by 80 minutes.  Patient went home with significant other released to self care.
Information has been received from a consumer concerning his approximately 20 year old female daughter with no pertinent medical history, drug reactions or allergies who on 07-MAY-2008 was vaccinated with a third dose of GARDASIL (Lot# number unknown). The dates of the first and second doses were not known at the time of the report. There was no concomitant medication. The reporter stated that "about a year ago" in approximately 2009 her daughter began experiencing weakness, fatigue, decreased appetite, muscle tremors, lightheadedness, dizziness and diarrhea. She had had several test completed and the results had all been negative. The mother mentioned that her daughter was hit by a car "last year" in 2009 while walking across the street. She did not sustain any broken bones, but she did hit her head and was sore following the accident. "Within the past two weeks" on approximately 05-JUL-2010 the patient "got really sick again and lost 9 pounds". Colonoscopy, blood work, CT scan and ultrasound tests were performed and the results were all normal. At the time of the report, the patient had not recovered. The patient sought medical attention by an office visit. Follow up information has been received by the physician who stated that this patient did not receive a GARDASIL injection by this office. Additional information is not  expected.
Patient ID:  87 y.o.      Admit Date:  8/30/2022     Discharge Date: 9/2/22     Principal Dx/ Final Dx:  Pneumonia of both lower lobes due to infectious organism     Relevant Inpt Dx:  Principal Problem:    Pneumonia of both lower lobes due to infectious organism  Active Problems:    Dementia    Essential hypertension    Stage 3a chronic kidney disease           HPI:     Hospital Course:    This elderly man was admitted with pneumonia.  It was felt to be bacterial.  He was treated with antibiotics and nebs and is improved.  Today his lungs are without wheezes.  He will complete antibiotics orally and will also complete steroids.  He did test positive for covid but was not given remdesivir for this.  I feel his pneumonia is bacterial, not viral.  He did have hemoptysis; CT showed no mass and this is improved.        He does have htn and his BP medications were adjusted.             Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  home     Discharge Condition:  fair
SWEATS; CHILLS; HEADACHE; EXHAUSTION; NAUSEOUS; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (SWEATS), CHILLS (CHILLS), HEADACHE (HEADACHE), FATIGUE (EXHAUSTION) and NAUSEA (NAUSEOUS) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (SWEATS), CHILLS (CHILLS), HEADACHE (HEADACHE), FATIGUE (EXHAUSTION) and NAUSEA (NAUSEOUS). At the time of the report, HYPERHIDROSIS (SWEATS), CHILLS (CHILLS), HEADACHE (HEADACHE), FATIGUE (EXHAUSTION) and NAUSEA (NAUSEOUS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
This is an initial spontaneous report from a contactable physician. This physician reported to a Pfizer sales representative that a male patient received a 2nd dose of PREVNAR 13, 0.5ml as childhood immunization on 26Oct2010, at 4 months of age. Relevant medical history was unknown. Relevant concomitant medication or vaccines was unknown. Past vaccine history included a first dose of PREVNAR 13 administered on 31Aug2010 at 2 months of age. On an unknown date, the patient developed a high fever, lethargy and pneumococcal meningitis. On 05Jan2011, (at approximately 6 months of age) the patient was admitted to the hospital in response to the events. Relevant laboratory data was unknown. Treatment was not specified. At the time of the report the patient had recovered from the events.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of Gardasil. Subsequently, the patient fell down and had a seizure. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.
(L) upper arm at injection site 31 mm redness site flat warm to touch. (R) upper arm at injection site 40 mm redness flat warm to touch.
Next day I had a headache, slightly achy, noticeable fatigue. Continued for a 2nd day, then abated.
received first dose of Shingrix on 1/13/2020 / not received the second dose to date; This case was reported by a pharmacist and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 13th January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter called on behalf of the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No patient demographics were provided. The reporter did not consent to follow up.
Itchy within 15 minutes; hot red weal within an hour; weal grew to 5 cm X 10 cm in 24 hours. Flu-like symptoms 9/26/2017 for about 8 hours. Achy joints when I awoke on 9/26/2017.
Resident received vaccination on January 15, 2021.  She was found unresponsive with shallow respirations on the morning of January 16, 2021 and was sent to ER via ambulance.  The resident was admitted to medical center ICU where she passed away later that day.
Numbness of the pinkie toe of the right foot. First noticed 2-3 weeks after first dose, still present 6 weeks after vaccination. Exacerbated after a hot shower and while walking.
Top and right side of right breast began itching within 6 hours of the vaccine,  with increased sensitivity from nipple to ribs. The itching continues now, 6 days later, but 4 days  after vaccine (2 days ago), the itching was compounded with pain (same area as itching) and lumps (some at the base of right breast, others even into right armpit). They are not visibly red nor are they warm to the touch, but I can feel them under the skin, unlike the same area on the left breast.
Pt to ED 8/12 for dyspnea and congestion.  Pt sinus tach upon arrival, rhonchi bilaterally with labored respirations, pt is a/ox2. Pt COVID+ 8/12. 8/13 rx to initiate remdesivir, to continue cefepime and azithromycin. 8/14 pt remains confused oriented x2 name and place only, when asked if in pain says no. 8/15 pt A&OX2, tube feeding started. 8/18 Pt in no apparent distress.  IV infusing and IV site is intact.  Tube feeding infusing without residual. 8/21 pt had spit up all over gown, there was left sided facial drooping noted. Patient was agonal breathing and unresponsive, chest compressions started immediately. The patient was pronounced at 0637.
Rash, went to ER for Prednisone 20 mg QD x5 days.
A hour after the vaccine I started having muscle aches and chills. Then I progressed into have a fever, and my body aches intensified. My asthma also became a probably I had to increase my medication. I also had bad headaches and diarrhea. I had swollen nymph lobes, that just went back to normal.
Patient presented to the ED on 11/3/2023 with complaints of cough, vomiting, and fever x 2 days.  Father reported 'he got more sick after flu and COVID booster'.  Tested negative for COVID on 10/31/23.
Cerebrovascular accident -patient with a recent diagnosis of Covid-19 who presented to the ED on 1/3/22 for CVA causing expressive aphasia and gargled speech, word salad. He received tPA 1/3/22 and transferred to hospital thereafter. Started on Metoprolol po. He remained stable, transferred to floor and was started on po Eliquis for OAC. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
ADACEL given 3-1-10 parent reports fever and nausea all day 3-2-10, pain at injection site, redness and swelling, headache, fever 102.2 early am then controlled with TYLENOL. 3-3-10 child had 99 temp in AM and had a lack of appetite.
Sudden sensorineural hearing loss on the LEFT. 2 weeks after vaccine. No other etiology identified. No trauma or illness.
Patient contacted pharmacy on 7/23/18 and reported that she got shingles after receiving the vaccine on 7/19/18. She is experiencing redness and red bumps on her stomach. She first thought the redness was contributed by her dog scratching her but now she is stating that it is shingles.
Drowsiness; hot flashes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Apr2021 (Lot number: EW0170) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergy: detergents" (unspecified if ongoing), notes: detergents. There were no concomitant medications. Past drug history included: Ciprofloxacin, reaction(s): "Drug allergy", notes: Ciprofloxacin. Vaccination history included: Bnt162b2 (Product: COVID 19 , Brand: Pfizer, Lot number: ER8734, Lot unknown: False, Administrator route: Intramuscular, Dose number: 1, Vaccine location: Left arm, Administration date: 04Apr2021), administration date: 04Apr2021, when the patient was 47 years old, for Covid-19 immunisation. The following information was reported: SOMNOLENCE (non-serious) with onset 25Apr2021, outcome "recovered" (2021), described as "Drowsiness"; HOT FLUSH (non-serious) with onset 25Apr2021, outcome "recovered" (2021), described as "hot flashes". Therapeutic measures were taken as a result of somnolence, hot flush.  Additional information: AE treatment includes Advil. There was no other vaccine in four weeks and no other medications in two weeks. The patient did not had Covid prior vaccination and did not tested for Covid post vaccination.  No follow-up attempts are possible. No further information is expected.
covid arm; red spot; itchy; warm; hot to touch; has gotten a lot larger; pain to the touch; armed turned red about an egg size; the redness has gotten bigger and it is a deep red; it feels like something is traveling up to the side of her neck; warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (covid arm), VACCINATION SITE ERYTHEMA (red spot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (warm) and VACCINATION SITE WARMTH (hot to touch) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history  is provided and concomitant drugs are provided.  Concomitant products included AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) and MELOXICAM as needed for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (covid arm), VACCINATION SITE ERYTHEMA (red spot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (warm), VACCINATION SITE WARMTH (hot to touch), VACCINATION COMPLICATION (has gotten a lot larger), VACCINATION SITE PAIN (pain to the touch), ERYTHEMA (armed turned red about an egg size), VACCINATION COMPLICATION (the redness has gotten bigger and it is a deep red), VACCINATION COMPLICATION (it feels like something is traveling up to the side of her neck) and FEELING HOT (warm to touch). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (covid arm), VACCINATION SITE ERYTHEMA (red spot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (warm), VACCINATION SITE WARMTH (hot to touch), VACCINATION COMPLICATION (has gotten a lot larger), VACCINATION SITE PAIN (pain to the touch), ERYTHEMA (armed turned red about an egg size), VACCINATION COMPLICATION (the redness has gotten bigger and it is a deep red), VACCINATION COMPLICATION (it feels like something is traveling up to the side of her neck) and FEELING HOT (warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
sore arm; redness; feverish; This is a spontaneous report from a non-contactable consumer or other non hcp. An 88-years-old female received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Not reported) via an unspecified route of administration, administered on 11Feb2021 as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Not reported) via an un-specified route of administration, administered on 21Jan2021 as a single dose for covid-19 immunisation. It was reported that patient received second shot of pfizer covid vaccine and patient was having a terrible reaction on arm. started hurting within hours, the puncture site Left Arm, started to turn red, and hard the size of an egg, patient arm started hurting within 15 minutes, that evening it started with redness and feverish feel to it was getting bigger and the redness is now working down the inside of arm. Patient was feeling out of it the day after patient got the vaccine, but only half a day, but it was the reaction that was now bothering. The outcome of the event was unknown at the time of report.   No follow up attempts are possible. information about lot/batch number cannot be obtained.
Fever; Chills; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. The patient id not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 at 17:00, the patient experienced fever, chills and sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills and sweats were recovered on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Broke out with pin dot rash on face, neck, chest, back, and shoulders. Took patient to see Dr. that afternoon, and he blamed the rash on her drying w/ a bathing suit on after swimming. The rash was nowhere under the areas that her bathing suit was on though. After researching it myself at home, I found that the reaction had to have come from the MMR vaccine she had just received. The doctor thought it would have come the day after the immunization if it was a reaction, but research shows that it can come anywhere up to 28 days out. Obviously this was a reaction!!! It has now been 8 days since the immunization was given and she still has the itchy bumps all over!
HORRIFIC SHINGLES POST SHINGLES VACCINATION/Suspected vaccination failure; HORRIFIC SHINGLES; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: HORRIFIC SHINGLES POST SHINGLES VACCINATION/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: HORRIFIC SHINGLES). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 16-MAR-2023 The case was received from the consumer via  interactive digital media. The reporter reported that funny 3 people he/she know personally contracted horrific shingles post shingles vaccination. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This is 1 of 3 linked cases reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR050702:same reporter, patient 2 US-GSK-US2023AMR050704:same reporter, patient 3